Important note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.
PR Newswire, Wednesday, 4 December 1996.
Schering Corporation is the exclusive licensee of this Biogen patent, as well as the related Biogen alpha interferon patent rights throughout the world. The Biogen alpha interferon patent rights cover, among other things, the recombinant production of alpha interferons, including Schering-Plough's INTRON(R) A (interferon alfa-2b).
The Schering suit was filed in U.S. District Court for the District of Delaware in Wilmington.
In Japan, Biogen filed a patent infringement lawsuit against Amgen Limited in 1994, charging that Amgen's efforts to develop and market consensus interferon in Japan infringe one of Biogen's Japanese alpha interferon patents.
Schering-Plough's INTRON A is approved in the United States for treating chronic hepatitis B and C, venereal warts, hairy cell leukemia, AIDS-related Kaposi's sarcoma and as adjuvant therapy for malignant melanoma. INTRON A is marketed in 68 countries worldwide for as many as 16 indications.
Schering-Plough is a research-based company engaged in the discovery, development, manufacturing and marketing of pharmaceutical and health care products worldwide. Biogen is based in Cambridge, Mass.
CONTACT: Media: Robert Consalvo, 201-822-7409, or Investors: Geraldine U. Foster, 201-822-7410, or Frank J. Murdolo, 201-822-7437, all of Schering- Plough/ 08:13 EST
961204
PR961210
Copyright © 1996 - PRNewswire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through PRNewswire, Permissions, 810 Seventh Ave., 32nd Floor, New York, NY 10019 http://www.prnewswire.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, National Library of Medicine, and donations from users like you.
Always watch for outdated information. This article first appeared in 1996. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 1996. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .